Louvet C, André T, Lledo G, Hammel P, Bleiberg H, Bouleuc C, Gamelin E, Flesch M, Cvitkovic E and de Gramont A. Gemcitabine combined with oxaliplatin (GEMOX) for advanced pancreatic adenocarcinoma : final results of a GERCOR multicenter phase II study. J Clin Oncol 2001, in press.

Louvet C, de Gramont A, Tournigand C, Artru P, Maindrault-Goebel F, Krulik M. Correlation between progression-free survival and response rate in metastatic colorectal cancer. Cancer 2001, 91 : 2033-38.

Tournigand C, Louvet C, Molitor JL, Dehni N, Lejeune V, Sezeur A, Pigne A, Marpeau L, Cady J, de Gramont A. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma. Gynecol Oncol 2001; 83: 198-204.

Louvet C, André T, Hammel P, Selle F, Landi B, Cattan S, Fonck M, Flesch M, Colin P, Balosso J, Ruszniewski P and A de Gramont. Phase II trial of bimonthly leucovorin, 5-fluorouracil and gembitabine for advanced pancreatic adenocarcinoma (FOLFUGEM). Ann of Oncol 2001; 12:675-9.

Maindrault-Goebel F, de Gramont A, Louvet C, André T, Carola E, Mabro M, Artru P, Gilles V, Lotz JP, Izrael V and Krulik M. High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7). Eur J Cancer 2001; 37:1000-5.

André T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E, Colbert N, Boaziz C, Piedbois P, Tubiana-Mathieu N, Boutan-Laroze A, Flesch M, Billiau V, Buyse M and de Gramont A. Randomized adjuvant study two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma : study design and preliminary safety results. Semin Oncol 2001; 28, supp 1:35-40.

Maindrault-Goebel F, de Gramont A, Louvet C, André T, Carola E, Gilles V, Lotz J.P, Tournigand C, Mabro M, Molitor J.L, Artru P, Izraël V et Krulik M. Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Ann Oncol 2000 ;11:1477-83

André T, Balosso J, Louvet C, Hannoun L, Houry S, Huguier M, Lotz J.P, de Gramont A, Bellaiche A, Parc R, Touboul E, Izraël V. Phase II trial of combined radiotherapy and chemotherapy as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 2000 ;46:903-911.

Maindrault-Goebel F, Louvet C, André T, Carola E, Lotz J.P, Molitor J.L, Garcia M.L, Gilles-Amar V, Izraël V, Krulik M, de Gramont A. Oxaliplatin added to the simplified bimonthly Leucovorin and 5-Fluorouracil regimen as second-line therapy for metastatic colorectal (FOLFOX6). Eur J Cancer 1999 ;9:1338-42.

André T, de Gramont A, Louvet C, Couteau C, Mabro M, Carola E, Lotz J.P, Maindrault Goebel F, Izraël V and Krulik M. CPT11 with bi-monthly high-dose Leucoverin and 5-Fluorouracil bolus and 46-hour continuous infusion in pretreated metastatic colorectal cancer (FOLFIRI). Eur J Cancer 1999 ;9:1343-47.

Tournigand C, Maindrault-Goebel F, Louvet C, de Gramont A, Krulik M. Severe anaphylactic reactions to oxaliplatin. Eur J Cancer 1998, 34:1297-98.

André T, Louvet C, Raymond E, Tournigand C, de Gramont A Bimonthly high-dose leucovorin, 5-Fluorouracil infusion and Oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same Leucovorin and 5-Fluorouracil regimen. Ann Oncol 1998 ;9:1-3.

de Gramont A, Louvet C, André T, Tournigand C, Krulik M. From the Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD). Bimonthly 48-hour Leucovorin plus 5-Fluorouracil in advanced colorectal cancer : Evaluation of a regimen. Eur J Cancer 1998 ;34:619-26.

Raymond E, de Gramont A, Louvet C, Tournigand C, Demuynck B, Beerblock K, Carola E, Krulik M. Clinical benefit with cisplatin, Hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma. Eur J Cancer 1997 ; 33:696-97.

Beerblock K, Rinaldi Y, André T, Louvet C, Varette C, Raymond E, Grange J.D, Favre R, De Gramond A, Krulik M. From the Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD). Bimonthly high-dose Leucovorin and 5-Fluorouracil 48-hour continuous infusion in advanced colorectal cancer. Cancer 1997;79:1100-5.